AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: RIVORY LP FINDLAY M CLARKE S BISHOP J
Citation: Lp. Rivory et al., TRACE ANALYSIS OF SN-38 IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 714(2), 1998, pp. 355-359

Authors: HAAZ MC DODDS HM RIOU JF RICHE C RIVORY LP ROBERT J
Citation: Mc. Haaz et al., IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - BIOSYNTHESIS AND ACTIVATION TO SN-38 BY HUMAN HEPATIC MICROSOMES, Annals of oncology, 9, 1998, pp. 221-221

Authors: RIVORY LP CLARKE S BISHOP JF ODONNELL A EMMETT L FINDLAY M
Citation: Lp. Rivory et al., IRINOTECAN (CPT-11) - A PRELIMINARY INVESTIGATION OF THE RELATIONSHIPBETWEEN TROUGH CONCENTRATIONS OF THE ACTIVE METABOLITE, SN-38, AND TOXICITY, Annals of oncology, 9, 1998, pp. 222-222

Authors: DODDS HM ROBERT J RIVORY LP
Citation: Hm. Dodds et al., THE DETECTION OF PHOTODEGRADATION PRODUCTS OF IRINOTECAN (CPT-11, CAMPTO(R), CAMPTOSAR(R)), IN CLINICAL-STUDIES, USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION MASS-SPECTROMETRY, Journal of pharmaceutical and biomedical analysis, 17(4-5), 1998, pp. 785-792

Authors: HAAZ MC RICHE C RIVORY LP ROBERT J
Citation: Mc. Haaz et al., BIOSYNTHESIS OF AN AMINOPIPERIDINO METABOLITE OF IRINOTECAN PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECINE] BY HUMAN HEPATIC MICROSOMES, Drug metabolism and disposition, 26(8), 1998, pp. 769-774

Authors: DODDS HM HAAZ MC RIOU JF ROBERT J RIVORY LP
Citation: Hm. Dodds et al., IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - PHARMACOLOGICAL PROPERTIES AND ACTIVATION TO SN-38, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 578-583

Authors: RIVORY LP HAAZ MC CANAL P LOKIEC F ARMAND JP ROBERT J
Citation: Lp. Rivory et al., PHARMACOKINETIC INTERRELATIONSHIPS OF IRINOTECAN (CPT-11) AND ITS 3 MAJOR PLASMA METABOLITES IN PATIENTS ENROLLED IN PHASE-I II TRIALS/, Clinical cancer research, 3(8), 1997, pp. 1261-1266

Authors: ROBERTS MS WU ZY RIVORY LP SMITHERS BM EGERTON WS WEISS M
Citation: Ms. Roberts et al., RELATIVE DISPERSION OF INTRAVASCULAR TRANSIT TIMES DURING ISOLATED HUMAN LIMB PERFUSIONS FOR RECURRENT MELANOMA, British journal of clinical pharmacology, 44(4), 1997, pp. 347-351

Authors: HAAZ MC RIVORY LP RICHE C ROBERT J
Citation: Mc. Haaz et al., THE TRANSFORMATION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE SN-38 BY HUMAN LIVER-MICROSOMES - DIFFERENTIAL HYDROLYSIS FOR THE LACTONE AND CARBOXYLATE FORMS, Naunyn-Schmiedeberg's archives of pharmacology, 356(2), 1997, pp. 257-262

Authors: DODDS HM CRAIK DJ RIVORY LP
Citation: Hm. Dodds et al., PHOTODEGRADATION OF IRINOTECAN (CPT-11) IN AQUEOUS-SOLUTIONS - IDENTIFICATION OF FLUORESCENT PRODUCTS AND INFLUENCE OF SOLUTION COMPOSITION, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1410-1416

Authors: LECOUTEUR DG RIVORY LP POND SM
Citation: Dg. Lecouteur et al., THE EFFECT OF OXIDATIVE INJURY ON HEPATOCELLULAR INFLUX OF LEUCINE INTHE RAT, HEPATOLOGY RESEARCH, 4(6), 1996, pp. 343-350

Authors: RIVORY LP AVENT KM POND SM
Citation: Lp. Rivory et al., EFFECTS OF LIPOPHILICITY AND PROTEIN-BINDING ON THE HEPATOCELLULAR UPTAKE AND HEPATIC DISPOSITION OF 2 ANTHRACYCLINES, DOXORUBICIN AND IODODOXORUBICIN, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 439-445

Authors: RIVORY LP
Citation: Lp. Rivory, IRINOTECAN (CPT-11) - A BRIEF OVERVIEW, Clinical and experimental pharmacology and physiology, 23(10-11), 1996, pp. 1000-1004

Authors: DODDS HM WALPOLE ET RIVORY LP STRONG RW POND SM
Citation: Hm. Dodds et al., DISPOSITION OF EPIRUBICIN AFTER INTRAARTERIAL ADMINISTRATION IN LIPIODOL TO PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Therapeutic drug monitoring, 18(5), 1996, pp. 537-543

Authors: BOURZAT JD VUILHORGNE M RIVORY LP ROBERT J COMMERCON A
Citation: Jd. Bourzat et al., SEMISYNTHESIS OF RPR 121056A, A MAJOR METABOLITE OF IRINOTECAN (CPT-11), Tetrahedron letters, 37(35), 1996, pp. 6327-6330

Authors: RIVORY LP RIOU JF HAAZ MC SABLE S VUILHORGNE M COMMERCON A POND SM ROBERT J
Citation: Lp. Rivory et al., IDENTIFICATION AND PROPERTIES OF A MAJOR PLASMA METABOLITE OF IRINOTECAN (CPT-11) ISOLATED FROM THE PLASMA OF PATIENTS, Cancer research, 56(16), 1996, pp. 3689-3694

Authors: RIVORY LP BOWLES MR ROBERT J POND SM
Citation: Lp. Rivory et al., CONVERSION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN (SN-38), BY HUMAN LIVER CARBOXYLESTERASE, Biochemical pharmacology, 52(7), 1996, pp. 1103-1111

Authors: LECOUTEUR D RIVORY LP YI C POND SM
Citation: D. Lecouteur et al., AGING, ACUTE OXIDATIVE INJURY AND HEPATOCELLULAR GLUCOSE-TRANSPORT INTHE RAT, HEPATOLOGY RESEARCH, 3(5), 1995, pp. 244-253

Authors: RIVORY LP CANAL P MATHIEUBOUE A ROBERT J
Citation: Lp. Rivory et al., PHARMACOKINETICS AND INTERCONVERSION OF THE CARBOXYLATE AND LACTONE FORMS OF IRINOTECAN (CPT-11) AND OF ITS METABOLITE SN-38 IN PATIENTS, European journal of cancer, 31A, 1995, pp. 956-956

Authors: RIVORY LP ROBERT J
Citation: Lp. Rivory et J. Robert, IDENTIFICATION AND KINETICS OF A BETA-GLUCURONIDE METABOLITE OF SN-38IN HUMAN PLASMA AFTER ADMINISTRATION OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 176-179

Authors: RIVORY LP ROBERT J
Citation: Lp. Rivory et J. Robert, MOLECULAR, CELLULAR, AND CLINICAL ASPECTS OF THE PHARMACOLOGY OF 20(S)CAMPTOTHECIN AND ITS DERIVATIVES, Pharmacology & therapeutics, 68(2), 1995, pp. 269-296

Authors: RIVORY LP ROBERT J
Citation: Lp. Rivory et J. Robert, PHARMACOLOGY OF CAMPTOTHECIN AND ITS DERI VATIVES, Bulletin du cancer, 82(4), 1995, pp. 265-285

Authors: RIVORY LP ROBERT J
Citation: Lp. Rivory et J. Robert, REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THESIMULTANEOUS QUANTITATION OF THE CARBOXYLATE AND LACTONE FORMS OF THECAMPTOTHECIN DERIVATIVE IRINOTECAN, CPT-11, AND ITS METABOLITE SN-38 IN PLASMA, Journal of chromatography B. Biomedical applications, 661(1), 1994, pp. 133-141

Authors: LECOUTEUR DG RIVORY LP POND SM
Citation: Dg. Lecouteur et al., GLUCOSE-TRANSPORT AND HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER, Journal of gastroenterology and hepatology, 9(4), 1994, pp. 385-390

Authors: LECOUTEUR DG RIVORY LP POND SM
Citation: Dg. Lecouteur et al., THE EFFECTS OF AGING AND NUTRITIONAL STATE ON HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER, Transplantation, 58(5), 1994, pp. 531-536
Risultati: 1-25 | 26-30